DMI-5207
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DMI-5207, covering 2013-12-06 to 2013-12-06. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema [Phase 2]